Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials

References

• Kuon R-J, Wallwiener L-M, Germeyer A, et al. Establishment of a standardized immunological diagnostic procedure in RM patients. J Reprod Immunol. 2012;94(1):55.
   Web of Science ®Google Scholar
• Christiansen OB, Nybo Andersen AM, Bosch E, et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril. 2005;83(4):821–839.
   PubMed Web of Science ®Google Scholar
• Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14(5):839–854.
   PubMed Web of Science ®Google Scholar
• Del RT, Ruffatti A, Visentin MS, et al. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study. J Rheumatol. 2013;40:392–402.
   Web of Science ®Google Scholar
• D’Ippolito S, Meroni PL, Koike T, et al. Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder. Autoimmun Rev. 2014;13(9):901–908.
   PubMed Web of Science ®Google Scholar
• Salmon JE, Girardi G, Lockshin MD. The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients. Nat Clin Pract Rheumatol. 2007;3(3):140–7; quiz 1 p following 187.
   PubMedGoogle Scholar
• Oku K, Amengual O, Atsumi T. Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome. Eur J Clin Invest. 2012;42(10):1126–1135.
   PubMed Web of Science ®Google Scholar
• Espinola RG, Liu X, Colden-Stanfield M, et al. E-Selectin mediates pathogenic effects of antiphospholipid antibodies. J Thromb Haemost. 2003;1(4):843–848.
   PubMed Web of Science ®Google Scholar
• Di Simone N, Raschi E, Testoni C, Castellani R, D’Asta M, Shi T, Krilis SA, Caruso A, Meroni PL, et al. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro. Ann Rheum Dis. 2005;64(3):462–467.
   PubMed Web of Science ®Google Scholar
• Di Simone N, Di Nicuolo F, D’Ippolito S, Castellani R, Tersigni C, Caruso A, Meroni P, Marana R, et al. Antiphospholipid antibodies affect human endometrial angiogenesis. Biol Reprod. 2010;83(2):212–219.
   PubMed Web of Science ®Google Scholar
• Girardi G, Yarilin D, Thurman JM, et al. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 2006;203(9):2165–2175.
   PubMed Web of Science ®Google Scholar
• Rai RS, Clifford K, Cohen H, et al. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod. 1995;10(12):3301–3304.
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.
   PubMed Web of Science ®Google Scholar
• Allison JL, Schust DJ. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Curr Opin Endocrinol Diabetes Obes. 2009;16(6):446–450.
   PubMed Web of Science ®Google Scholar
• Cayol V, Reznikoff MF, Trabelsi K, et al. Role of aspirin in the preventive treatment of recurrent miscarriages. Rev Prat Gynecol Obstet. 2001:21–22.
   Google Scholar
• Gerosa M, Chighizola C, Meroni PL. Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases). Intern Emerg Med. 2008;3(3):201–203.
   PubMed Web of Science ®Google Scholar
• Bose P, Kadyrov M, Goldin R, et al. Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta. 2006;27(8):869–875.
   PubMed Web of Science ®Google Scholar
• Dahl OE, Eriksson BI, Agnelli G, et al. Postoperative melagatran/ximelagatran for the Prevention of venous thromboembolism following Major Elective Orthopaedic Surgery. Clin Drug Invest. 2005;25(1):65–77.
   PubMed Web of Science ®Google Scholar
• Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med. 2004;10(11):1222–1226.
   PubMed Web of Science ®Google Scholar
• Walker ID, Kujovich JL, Greer IA. The use of LMWH in pregnancies at risk: new evidence or perception? J Thromb Haemost. 2005;3(4):778–779.
   PubMed Web of Science ®Google Scholar
• Alijotas-Reig J, Vilardell-Tarres M. Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies? Obstet Gynecol Surv. 2010;65(1):39–45.
   PubMed Web of Science ®Google Scholar
• Derksen RH, Khamashta MA, Branch DW. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum. 2004;50(4):1028–1039.
   PubMed Web of Science ®Google Scholar
• Kwak-Kim J, Agcaoili MSL, Aleta L, et al. Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome. Am J Reprod Immunol. 2013;69(6):596–607.
   PubMed Web of Science ®Google Scholar
• Hoppe B, Burmester GR, Dörner T. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome). Curr Opin Rheumatol. 2011;23(3):299–304.
   PubMed Web of Science ®Google Scholar
• Empson MB, Lassere M, Craig JC, et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005:CD002859:CD002859.
   PubMed Web of Science ®Google Scholar
• Ziakas PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol. 2010;115:997–998. Author reply:8.
   Web of Science ®Google Scholar
• Mak A, Cheung MWL, Cheak AA, et al. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology. 2010;49(2):281–288.
   PubMed Web of Science ®Google Scholar
• Zhang T, Ye X, Zhu T, et al. Antithrombotic treatment for recurrent miscarriage:bayesian network meta-analysis and systematic review. Medicine. 2015;94(45):e1732.
   PubMed Web of Science ®Google Scholar
• Andreoli L, Chighizola CB, Banzato A, et al. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res. 2013;65(11):1869–1873.
   Web of Science ®Google Scholar
• Pierangeli SS, de Groot PG, Dlott J, et al. ‘Criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010. Lupus. 2011;20(2):182–190.
   PubMed Web of Science ®Google Scholar
• Ruffatti A, Salvan E, Del Ross TD, et al. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Thromb Haemost. 2014;112(4):727–735.
   PubMed Web of Science ®Google Scholar
• Mekinian A, Alijotas-Reig J, Carrat F, et al. Refractory obstetrical antiphospholipid syndrome: features, treatment and outcome in a European multicentre retrospective study. Autoimmun Rev. 2017.
   Web of Science ®Google Scholar
• Mekinian A, Costedoat-Chalumeau N, Masseau A, et al. Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome? Autoimmun Rev. 2015;14(1):23–29.
   PubMed Web of Science ®Google Scholar
• Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996;174(5):1584–1589.
   PubMed Web of Science ®Google Scholar
• Rai R, Cohen H, Dave M, et al. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997;314(7076):253–257.
   PubMed Web of Science ®Google Scholar
• Farquharson R, Kent N. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol. 2002;100(3):408–413.
   PubMed Web of Science ®Google Scholar
• Franklin RD, Kutteh WH. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Hum Reprod. 2003;18:1553–4; author reply 1554. author reply:4.
   PubMed Web of Science ®Google Scholar
• Triolo G, Ferrante A, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheumatol. 2003;48:728–731.
   PubMed Web of Science ®Google Scholar
• Goel N, Tuli A, Choudhry R. The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies. Med Sci Monit. 2006;12(3):CR132–CR136.
   PubMed Web of Science ®Google Scholar
• Dendrinos S, Sakkas E, Makrakis E. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2009;104(3):223–225.
   PubMed Web of Science ®Google Scholar
• Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, Kingdom JC, Barrett J, Gent M, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol. 2009;36(2):279–287.
   PubMed Web of Science ®Google Scholar
• Mohamed KAA, Saad AS. Enoxaparin and aspirin therapy for recurrent pregnancy loss due to anti-phospholipid syndrome (APS). Middle East Fertil Soc J. 2014;19(3):176–182.
   Google Scholar
• Ismail AM, Hamed AH, Saso S, et al. Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2016;132(2):219–223.
   Web of Science ®Google Scholar
• Zhou X. The effect of aspirin combined with low molecular weight heparin in treatment of 30 patients with habitual abortion and antiphospholipid syndrome. Cn Mod Doct. 2012;50:60–62.
   Google Scholar
• Tang H, Huang MY, Tan Y. Effect of low molecular weight heparin combined with low-dose aspirin for ACA positive recurrent spontaneous abortion. Hainan Med J. 2012;23:13–14.
   Google Scholar
• Cowchock S, Reece EA. Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial Am J Obstet Gynecol. 1997;176(5):1099–1100.
   PubMed Web of Science ®Google Scholar
• Tulppala M, Marttunen M, Söderstrom-Anttila V, et al. Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Hum Reprod. 1997;12(7):1567–1572.
   PubMed Web of Science ®Google Scholar
• Pattison NS, Chamley LW, Birdsall M, et al. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol. 2000;183(4):1008–1012.
   PubMed Web of Science ®Google Scholar
• Cowchock FS, Reece EA, Balaban D, et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992;166(5):1318–1323.
   PubMed Web of Science ®Google Scholar
• Guo LJ. Study of heparin on pregnant woman with recurrent pregnant loss and positive anti-phospholipid antibody. China Prac Med. 2013;8:57–59.
   Google Scholar
• Bu MX. Clinical observation 40 autoimmune habitual abortion patients with low molecular weight heparin calcium. China Prac Med. 2009;4:73–74.
   Google Scholar
• Fu JH, Wang ZY, Lang FF. Study of heparin on pregnant woman with recurrent pregnant loss and positive anti-phospholipid antibody. Chin J Perinat Med. 2004;7:276–278.
   Google Scholar